Kamath Rajesh, Sebastian Chris, Jayapriya Varshini R, Acharya Siddhartha Sankar, Kamat Ashok, Brand Helmut, D'Souza Reshma Maria Cocess, Salins Prajwal, Sugunan Aswin, Kamath Sagarika, Kamath Sangita G, Kini Sanjay B
Department of Healthcare and Hospital Management, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal 576104, India.
Department of Medical Administration, Tata Memorial Hospital, Mumbai 400012, India.
Int J Environ Res Public Health. 2025 Aug 18;22(8):1289. doi: 10.3390/ijerph22081289.
Out-of-pocket expenditure (OOPE) comprises 62% of national health expenditure in India. This heavy reliance on direct payments has engendered economic vulnerability and catastrophic financial pressures (typically defined as out-of-pocket spending exceeding a certain threshold of household income, leading to financial hardship) on households in a country where public health spending remains below targeted levels. The onset of the COVID-19 pandemic intensified these financial hardships further, as both total healthcare spending and OOPE experienced significant escalations due to the increased need for emergency care, vaccination efforts, and expanded health infrastructure. A retrospective, single-center study was conducted using data from COVID-19 patients admitted between June 2020 and June 2022. Patient data were collected from the Medical Records, IT, and Finance departments. A validated proforma was used for data extraction. Descriptive statistics were calculated, and the Shapiro-Wilk test was applied to assess normality of billing and OOPE data. Patients were stratified into three groups based on their insurance status, allowing for comparative analysis of OOPE percentages and absolute expenditures. The 2715 COVID-19 patients were categorized into three groups according to their health financing: those covered under AB-PMJAY (42.76%), private health insurance (22.16%), and the uninsured (35%). While the median billing amounts were comparable across these groups (ranging between INR 85,000 and INR 90,000), a substantial disparity was observed in terms of financial burden. All patients covered under AB-PMJAY incurred no OOPE, whereas privately insured patients had a median OOPE that constituted approximately 21% of their total billing amounts, with significant variability among different insurers. The uninsured group represented 35% of the cases and experienced the highest median OOPE, indicating substantial financial risk. The COVID-19 pandemic has revealed critical gaps in India's health financing framework. This study emphasizes the strong financial protection provided by AB-PMJAY, while also exposing the limitations of private health insurance in shielding patients from substantial healthcare costs. As the country progresses toward universal health coverage, there is a pressing need to expand public health insurance schemes that are inclusive, equitable, and effectively implemented. Additionally, strengthening regulation and accountability in the private insurance sector is essential. The study findings reinforce that AB-PMJAY has been highly successful in reducing OOPE and enhancing financial risk protection. Although private insurance reduced OOPE, patients still faced considerable expenses. The stark difference in OOPE of 100% for uninsured patients, 21.16% for privately insured, and 0% for AB-PMJAY beneficiaries underscores the importance of further expanding AB-PMJAY to reach more vulnerable populations.
自付费用(OOPE)占印度国家卫生支出的62%。在一个公共卫生支出仍低于目标水平的国家,对直接支付的严重依赖导致了家庭的经济脆弱性和灾难性财务压力(通常定义为自付支出超过家庭收入的某个阈值,导致财务困难)。新冠疫情的爆发进一步加剧了这些财务困难,因为由于对急诊护理、疫苗接种工作和扩大卫生基础设施的需求增加,医疗总支出和自付费用都大幅上升。一项回顾性单中心研究使用了2020年6月至2022年6月期间收治的新冠患者的数据。患者数据从病历、信息技术和财务部门收集。使用经过验证的表格进行数据提取。计算了描述性统计数据,并应用夏皮罗-威尔克检验来评估计费和自付费用数据的正态性。根据患者的保险状况将其分为三组,以便对自付费用百分比和绝对支出进行比较分析。2715名新冠患者根据其医疗融资情况分为三组:阿育吠陀-总理-杰纳阿罗克亚计划(AB-PMJAY)覆盖的患者(42.76%)、私人医疗保险覆盖的患者(22.16%)和未参保患者(35%)。虽然这些组的中位数计费金额相当(在85000印度卢比至90000印度卢比之间),但在财务负担方面存在很大差异。所有AB-PMJAY覆盖的患者均无自付费用,而私人参保患者的自付费用中位数约占其总计费金额的21%,不同保险公司之间存在显著差异。未参保组占病例的35%,自付费用中位数最高,表明存在重大财务风险。新冠疫情揭示了印度卫生融资框架中的关键差距。这项研究强调了AB-PMJAY提供的强大财务保护,同时也暴露了私人医疗保险在保护患者免受高额医疗费用影响方面的局限性。随着该国朝着全民健康覆盖迈进,迫切需要扩大具有包容性、公平性且有效实施的公共医疗保险计划。此外,加强对私人保险部门的监管和问责至关重要。研究结果强化了AB-PMJAY在减少自付费用和增强财务风险保护方面非常成功。虽然私人保险降低了自付费用,但患者仍面临相当大的费用。未参保患者自付费用为100%、私人参保患者为21.16%、AB-PMJAY受益人为0%的巨大差异凸显了进一步扩大AB-PMJAY以覆盖更多弱势群体的重要性。